Rhenman & Partners Asset Management AB as of June 30, 2022
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 86 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cigna Corp (CI) | 3.3 | $29M | 111k | 263.52 | |
| Eli Lilly & Co. (LLY) | 3.3 | $29M | 90k | 324.23 | |
| Abbvie (ABBV) | 3.3 | $29M | 190k | 153.16 | |
| UnitedHealth (UNH) | 3.3 | $29M | 56k | 513.62 | |
| Pfizer (PFE) | 3.2 | $28M | 540k | 52.43 | |
| Anthem (ELV) | 3.1 | $28M | 57k | 482.58 | |
| Boston Scientific Corporation (BSX) | 3.1 | $27M | 725k | 37.27 | |
| CVS Caremark Corporation (CVS) | 3.1 | $27M | 290k | 92.66 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.0 | $27M | 95k | 281.79 | |
| Horizon Therapeutics Pub L SHS | 2.9 | $26M | 325k | 79.76 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.8 | $25M | 160k | 156.01 | |
| Merck & Co (MRK) | 2.7 | $24M | 265k | 91.17 | |
| McKesson Corporation (MCK) | 2.3 | $21M | 63k | 326.21 | |
| Thermo Fisher Scientific (TMO) | 2.3 | $20M | 37k | 543.29 | |
| Humana (HUM) | 2.3 | $20M | 43k | 468.07 | |
| Abbott Laboratories (ABT) | 2.1 | $19M | 170k | 108.65 | |
| Abiomed | 2.1 | $18M | 73k | 247.51 | |
| Johnson & Johnson (JNJ) | 2.0 | $18M | 100k | 177.51 | |
| AmerisourceBergen (COR) | 2.0 | $18M | 125k | 141.48 | |
| Intuitive Surgical Com New (ISRG) | 1.6 | $14M | 70k | 200.71 | |
| Tenet Healthcare Corp Com New (THC) | 1.6 | $14M | 261k | 52.56 | |
| Danaher Corporation (DHR) | 1.6 | $14M | 54k | 253.52 | |
| Axonics Modulation Technolog (AXNX) | 1.5 | $14M | 240k | 56.67 | |
| Shockwave Med | 1.5 | $14M | 71k | 191.17 | |
| Medtronic SHS (MDT) | 1.5 | $14M | 150k | 89.75 | |
| Biontech Se Sponsored Ads (BNTX) | 1.5 | $13M | 90k | 149.10 | |
| Mirati Therapeutics | 1.4 | $13M | 190k | 67.13 | |
| Harmony Biosciences Hldgs In (HRMY) | 1.4 | $13M | 260k | 48.77 | |
| Gilead Sciences (GILD) | 1.4 | $12M | 200k | 61.81 | |
| BioMarin Pharmaceutical (BMRN) | 1.3 | $12M | 140k | 82.87 | |
| Cooper Cos Com New | 1.3 | $12M | 37k | 313.11 | |
| Becton, Dickinson and (BDX) | 1.3 | $11M | 45k | 246.53 | |
| Alnylam Pharmaceuticals (ALNY) | 1.2 | $11M | 75k | 145.85 | |
| Dynavax Technologies Corp Com New (DVAX) | 1.1 | $10M | 800k | 12.59 | |
| Apellis Pharmaceuticals (APLS) | 1.1 | $9.5M | 210k | 45.22 | |
| Neurocrine Biosciences (NBIX) | 1.1 | $9.3M | 95k | 97.48 | |
| Inspire Med Sys (INSP) | 1.0 | $9.1M | 50k | 182.68 | |
| Cytokinetics Com New (CYTK) | 1.0 | $9.0M | 230k | 39.29 | |
| Privia Health Group (PRVA) | 1.0 | $8.7M | 300k | 29.12 | |
| Regeneron Pharmaceuticals (REGN) | 0.9 | $8.3M | 14k | 591.14 | |
| Xencor (XNCR) | 0.9 | $8.2M | 300k | 27.37 | |
| Seagen | 0.9 | $8.0M | 45k | 176.94 | |
| Intra Cellular Therapies (ITCI) | 0.9 | $8.0M | 140k | 57.08 | |
| Veeva Sys Cl A Com (VEEV) | 0.9 | $7.5M | 38k | 198.05 | |
| R1 RCM (RCM) | 0.8 | $6.8M | 325k | 20.96 | |
| Silk Road Medical Inc Common | 0.7 | $6.4M | 175k | 36.39 | |
| Royalty Pharma Shs Class A (RPRX) | 0.7 | $6.3M | 150k | 42.04 | |
| Revance Therapeutics | 0.7 | $6.2M | 450k | 13.82 | |
| Iovance Biotherapeutics (IOVA) | 0.7 | $5.9M | 530k | 11.04 | |
| Esperion Therapeutics (ESPR) | 0.7 | $5.7M | 900k | 6.36 | |
| ImmunoGen | 0.6 | $5.4M | 1.2M | 4.50 | |
| Immunocore Hldgs Ads (IMCR) | 0.6 | $5.2M | 140k | 37.31 | |
| Alkermes SHS (ALKS) | 0.5 | $4.5M | 150k | 29.79 | |
| Edwards Lifesciences (EW) | 0.5 | $4.3M | 45k | 95.09 | |
| Align Technology (ALGN) | 0.5 | $4.3M | 18k | 236.67 | |
| Aerie Pharmaceuticals | 0.5 | $4.2M | 562k | 7.50 | |
| Hca Holdings (HCA) | 0.5 | $4.2M | 25k | 168.08 | |
| Novocure Ord Shs (NVCR) | 0.5 | $4.2M | 60k | 69.50 | |
| Glaukos (GKOS) | 0.5 | $4.1M | 90k | 45.42 | |
| Allogene Therapeutics (ALLO) | 0.5 | $4.0M | 350k | 11.40 | |
| Myovant Sciences | 0.4 | $3.9M | 310k | 12.43 | |
| Guardant Health (GH) | 0.4 | $3.8M | 95k | 40.34 | |
| Meiragtx Holdings (MGTX) | 0.4 | $3.8M | 500k | 7.57 | |
| Agilon Health (AGL) | 0.4 | $3.6M | 165k | 21.83 | |
| EXACT Sciences Corporation (EXAS) | 0.3 | $3.0M | 76k | 39.39 | |
| 1life Healthcare | 0.3 | $2.9M | 375k | 7.84 | |
| Sangamo Biosciences (SGMO) | 0.3 | $2.9M | 700k | 4.14 | |
| Teladoc (TDOC) | 0.3 | $2.8M | 85k | 33.21 | |
| Outset Med | 0.3 | $2.7M | 180k | 14.86 | |
| Viewray (VRAYQ) | 0.3 | $2.7M | 1.0M | 2.65 | |
| Progyny (PGNY) | 0.3 | $2.6M | 90k | 29.06 | |
| Health Catalyst (HCAT) | 0.3 | $2.6M | 180k | 14.49 | |
| Intellia Therapeutics (NTLA) | 0.3 | $2.6M | 50k | 51.76 | |
| Nkarta (NKTX) | 0.3 | $2.5M | 200k | 12.32 | |
| Iveric Bio | 0.3 | $2.4M | 250k | 9.62 | |
| Olink Hldg Ab Sponsored Ads (OLK) | 0.2 | $2.1M | 140k | 15.20 | |
| Arvinas Ord (ARVN) | 0.2 | $2.1M | 50k | 42.10 | |
| Nektar Therapeutics | 0.2 | $2.1M | 550k | 3.80 | |
| Phathom Pharmaceuticals (PHAT) | 0.2 | $2.0M | 235k | 8.44 | |
| Phreesia (PHR) | 0.2 | $1.9M | 75k | 25.01 | |
| Ionis Pharmaceuticals (IONS) | 0.2 | $1.9M | 50k | 37.02 | |
| G1 Therapeutics | 0.2 | $1.6M | 316k | 4.94 | |
| Stereotaxis Com New (STXS) | 0.2 | $1.5M | 797k | 1.84 | |
| Rigel Pharmaceuticals Com New | 0.2 | $1.4M | 1.2M | 1.13 | |
| Rapid Micro Biosystems Class A Com (RPID) | 0.1 | $1.3M | 300k | 4.30 | |
| Essa Pharma Com New (EPIX) | 0.1 | $1.2M | 375k | 3.15 |
